The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Inclusion of people living with HIV in Food and Drug Administration (FDA) oncology pivotal registration trials from 2020 to 2024.
 
Alberto Giovanni Leone
No Relationships to Disclose
 
Mark Lythgoe
No Relationships to Disclose
 
Jeremy Warner
Stock and Other Ownership Interests - HemOnc.org
Honoraria - Henry Ford Health System; Prime Healthcare Services
Consulting or Advisory Role - Lewin Group; Melax Tech; Westat
Other Relationship - HemOnc.org
 
Claudia Fulgenzi
No Relationships to Disclose
 
Marlie Smith
No Relationships to Disclose
 
David Benjamin
Consulting or Advisory Role - AiMed; Astellas Pharma; AVEO; Bayer; Eisai; EMD Serono; Exelixis; Janssen; Seagen
Speakers' Bureau - Merck
Travel, Accommodations, Expenses - DAVA Oncology; Merck; Seagen
 
Jonathan Krell
No Relationships to Disclose
 
Mark Nelson
No Relationships to Disclose
 
Margherita Bracchi
No Relationships to Disclose
 
Adam Temple
No Relationships to Disclose
 
Marta Boffito
No Relationships to Disclose
 
Filippo Pietrantonio
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bayer; BeiGene; Bristol-Myers Squibb; Daiichi-Sankyo; Ipsen; Johnson&Johnson; Merck Serono; MSD Oncology; Pierre Fabre; Rottapharm Biotech; Seagen; SERVIER; Takeda
Consulting or Advisory Role - Agenus; Amgen; Astellas Pharma; AstraZeneca; Bayer; BeiGene; BMS; Daiichi-Sankyo; Gilead Sciences; GlaxoSmithKline; Incyte; Jazz Pharmaceuticals,; Johnson & Johnson/Janssen; Merck Serono; MSD Oncology; Pfizer; Pierre Fabre; Rottapharm Biotech; SERVIER; Takeda
Research Funding - Agenus (Inst); Amgen (Inst); Astrazeneca (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Lilly (Inst); Rottapharm Biotech (Inst)
Travel, Accommodations, Expenses - Merck Serono; Pierre Fabre; Takeda Science Foundation
 
Pascal Migaud
No Relationships to Disclose
 
Dario Trapani
No Relationships to Disclose
 
David Pinato
Honoraria - Avammune; Boston Scientific; Bristol-Myers Squibb; Da Volterra; Galapagos NV; Lift Biosciences; Mursla Bio; Parabilis; Roche/Genentech; Starpharma; TERUMO
Consulting or Advisory Role - AstraZeneca; Da Volterra; EISAI; H3 Biomedicine; Ipsen; Mina Therapeutics; Roche
Speakers' Bureau - Bayer; Falk Pharma; Roche; ViiV Healthcare
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); MSD Oncology (Inst)
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; MSD Oncology
Other Relationship - Wiley
 
Alessia Dalla Pria
No Relationships to Disclose
 
Mark Bower
Honoraria - Gilead Sciences; ViiV Healthcare